Literature DB >> 27228176

WITHDRAWN: Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Tamir Epstein1, Nikolaos A Patsopoulos, Mark Weiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27228176     DOI： 10.1002/14651858.CD005041.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


× No keyword cloud information.
  2 in total

1.  The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Authors:  Kim Boesen; Luis Carlos Saiz; Juan Erviti; Ole Jakob Storebø; Christian Gluud; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Evid Based Med       Date:  2017-07-13

2.  Adding extended-release methylphenidate to psychological intervention for treatment of methamphetamine dependence: A double-blind randomized controlled trial.

Authors:  Alireza Noroozi; Seyed Abbas Motevalian; Mohammad-Reza Zarrindast; Javad Alaghband-Rad; Shahin Akhondzadeh
Journal:  Med J Islam Repub Iran       Date:  2020-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.